Quick Answer
Altamira Therapeutics Ltd. reported Gross Profit of -$1.14 million for fiscal year 2022.
Altamira Therapeutics Ltd. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2022 | -$1.14M | +47.7% |
| 2021 | -$2.18M | — |
- Altamira Therapeutics Ltd. showed an increase of +47.7% in Gross Profit compared to the prior fiscal year.
- Over the 2021–2022 period, Altamira Therapeutics Ltd.’s gross profit has grown by 47.7% (from -$2.18 million to -$1.14 million).
- The most recent figure is from Altamira Therapeutics Ltd.’s fiscal year 2022 report (Form 20-F), filed with the SEC on May 16, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: